Jul 24 |
Gilead Sciences: The Upcycle Is Just Getting Started
|
Jul 24 |
Full Efficacy and Safety Results for Gilead Investigational Twice-Yearly Lenacapavir for HIV Prevention Presented at AIDS 2024
|
Jul 23 |
Invest $50K in CVS Health and Gilead Sciences to Become a Dividend Millionaire
|
Jul 23 |
ViiV's Dovato as effective as Gilead's Biktarvy for HIV but with less weight gain
|
Jul 23 |
ViiV Healthcare’s Dovato as effective as Biktarvy in Phase IV HIV trial
|
Jul 23 |
Nanotechnology in medicine: Who are the leading public companies?
|
Jul 22 |
Gilead Sciences (GILD) Stock Declines While Market Improves: Some Information for Investors
|
Jul 22 |
UNAIDS boss calls on Gilead to provide ‘miracle’ drug to developing countries
|
Jul 22 |
Gilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership to Help Address the Growing HIV Crisis in Eastern Europe and Central Asia
|
Jul 20 |
Gilead Sciences' (NASDAQ:GILD) one-year decline in earnings translates into losses for shareholders
|